Product Code: PM3098
The global nicotinamide adenine dinucleotide market size is expected to reach USD 1,722.11 million by 2032, according to a new study by Polaris Market Research. The report "Nicotinamide Adenine Dinucleotide Market Share, Size, Trends, Industry Analysis Report, By Grade (Food Grade, Pharmaceutical Grade, and Others); By Application; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Increasing product penetration as a key supplement for a variety of food ingredients because of the NAD's antioxidant properties coupled with the surge in consumer awareness regarding the health benefits of the product and continuously growing healthcare spending capacity of people across both developed and developing countries are key factors expected to boost the market growth. Moreover, the increasing focus of major market players on developing more advanced and innovative solutions to tackle various issues associated with human health through heavily investing in R&D activities is also creating huge growth opportunities in the market.
NAD+ has been studied extensively across the globe over the last few decades and continues to receive current research attention as several new roles and functions of this cofactor have significantly emerged in the regulation of protein modifications that could help regulate cellular metabolism and a wide range of cellular events. Recent studies have also shown that NAD+ levels can profoundly eliminate or reduce cell damage in catabolic tissue, including the brain. Therefore, the promotion of intracellular NAD+ anabolism shows promising market growth.
Moreover, the NAD+ concentration increases under various conditions associated with reduced energy loads, including glucose deprivation, fasting, caloric restriction, and exercise. Apart from this, these levels are highly elevated under conditions of increased life span or health span, representing a major contributor to aging. Thus, supplementation with the product and its precursors might define a potential therapeutic strategy to mediate protection against the accumulation of inflammation and highly volatile ROS during aging.
Nicotinamide Adenine Dinucleotide Market Report Highlights:
Food grade segment accounted for over considerable global market share in 2022, which is mainly accelerated by its growing adoption as a substrate across various biological processes including DNA repair
Dietary supplements segment dominated the global market in 2022, on account of the widespread adoption of product as an alternative for vitamins and having the ability to help in living longer and healthier lives
Asia Pacific region is expected to witness highest growth rate throughout the forecast period, owing to increasing consumer proliferation for improving immunization and high product adoption across the pharma sector
The global key market players include Jubilant Life Sciences, TCI Chemicals, Vertellus Holdings, Zhenjiang Lanbo Biotechnology, Himedia Laboratories, and Catalent.
Polaris Market Research has segmented the nicotinamide adenine dinucleotide market report based on grade, application, and region:
Nicotinamide Adenine Dinucleotide, Grade Outlook (Revenue - USD Million, 2019 - 2032)
Food Grade
Pharmaceutical Grade
Others
Nicotinamide Adenine Dinucleotide, Application Outlook (Revenue - USD Million, 2019 - 2032)
Dietary Supplements
Pharmaceuticals
Anti-aging Products
Others
- Nicotinamide Adenine Dinucleotide, Regional Outlook (Revenue - USD Million, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Nicotinamide Adenine Dinucleotide Market Insights
- 4.1. Nicotinamide Adenine Dinucleotide Market - Industry Snapshot
- 4.2. Nicotinamide Adenine Dinucleotide Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growing number of product applications in biochemistry
- 4.2.1.2. Rising consumer demand for anti-aging products
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Government regulations on dosage
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Nicotinamide Adenine Dinucleotide Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Nicotinamide Adenine Dinucleotide Market, by Grade
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Nicotinamide Adenine Dinucleotide, by Grade, 2019-2032 (USD Million)
- 5.3. Food Grade
- 5.3.1. Global Nicotinamide Adenine Dinucleotide Market, by Food Grade, by Region, 2019-2032 (USD Million)
- 5.4. Pharmaceutical Grade
- 5.4.1. Global Nicotinamide Adenine Dinucleotide Market, by Pharmaceutical Grade, by Region, 2019-2032 (USD Million)
- 5.5. Others
- 5.5.1. Global Nicotinamide Adenine Dinucleotide Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Nicotinamide Adenine Dinucleotide Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 6.3. Dietary Supplements
- 6.3.1. Global Nicotinamide Adenine Dinucleotide Market, by Dietary Supplements, by Region, 2019-2032 (USD Million)
- 6.4. Pharmaceuticals
- 6.4.1. Global Nicotinamide Adenine Dinucleotide Market, by Pharmaceuticals, by Region, 2019-2032 (USD Million)
- 6.5. Anti-aging Products
- 6.5.1. Global Nicotinamide Adenine Dinucleotide Market, by Anti-aging Products, by Region, 2019-2032 (USD Million)
- 6.6. Others
- 6.6.1. Global Nicotinamide Adenine Dinucleotide Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Nicotinamide Adenine Dinucleotide Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Nicotinamide Adenine Dinucleotide Market Assessment, By Geography, 2019-2032 (USD Million)
- 7.3. Nicotinamide Adenine Dinucleotide Market - North America
- 7.3.1. North America: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.3.2. North America: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.3.3. Nicotinamide Adenine Dinucleotide Market - U.S.
- 7.3.3.1. U.S.: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.3.3.2. U.S.: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.3.4. Nicotinamide Adenine Dinucleotide Market - Canada
- 7.3.4.1. Canada: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.3.4.2. Canada: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.4. Nicotinamide Adenine Dinucleotide Market - Europe
- 7.4.1. Europe: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.4.2. Europe: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.4.3. Nicotinamide Adenine Dinucleotide Market - UK
- 7.4.3.1. UK: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.4.3.2. UK: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.4.4. Nicotinamide Adenine Dinucleotide Market - France
- 7.4.4.1. France: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.4.4.2. France: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.4.5. Nicotinamide Adenine Dinucleotide Market - Germany
- 7.4.5.1. Germany: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.4.5.2. Germany: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.4.6. Nicotinamide Adenine Dinucleotide Market - Italy
- 7.4.6.1. Italy: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.4.6.2. Italy: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.4.7. Nicotinamide Adenine Dinucleotide Market - Spain
- 7.4.7.1. Spain: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.4.7.2. Spain: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.4.8. Nicotinamide Adenine Dinucleotide Market - Netherlands
- 7.4.8.1. Netherlands: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.4.8.2. Netherlands: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.4.9. Nicotinamide Adenine Dinucleotide Market - Russia
- 7.4.9.1. Russia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.4.9.2. Russia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.5. Nicotinamide Adenine Dinucleotide Market - Asia Pacific
- 7.5.1. Asia Pacific: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.5.2. Asia Pacific: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.5.3. Nicotinamide Adenine Dinucleotide Market - China
- 7.5.3.1. China: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.5.3.2. China: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.5.4. Nicotinamide Adenine Dinucleotide Market - India
- 7.5.4.1. India: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.5.4.2. India: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.5.5. Nicotinamide Adenine Dinucleotide Market - Malaysia
- 7.5.5.1. Malaysia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.5.5.2. Malaysia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.5.6. Nicotinamide Adenine Dinucleotide Market - Japan
- 7.5.6.1. Japan: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.5.6.2. Japan: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.5.7. Nicotinamide Adenine Dinucleotide Market - Indonesia
- 7.5.7.1. Indonesia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.5.7.2. Indonesia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.5.8. Nicotinamide Adenine Dinucleotide Market - South Korea
- 7.5.8.1. South Korea: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.5.8.2. South Korea: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.6. Nicotinamide Adenine Dinucleotide Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.6.2. Middle East & Africa: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.6.3. Nicotinamide Adenine Dinucleotide Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.6.3.2. Saudi Arabia: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.6.4. Nicotinamide Adenine Dinucleotide Market - UAE
- 7.6.4.1. UAE: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.6.4.2. UAE: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.6.5. Nicotinamide Adenine Dinucleotide Market - Israel
- 7.6.5.1. Israel: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.6.5.2. Israel: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.6.6. Nicotinamide Adenine Dinucleotide Market - South Africa
- 7.6.6.1. South Africa: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.6.6.2. South Africa: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.7. Nicotinamide Adenine Dinucleotide Market - Latin America
- 7.7.1. Latin America: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.7.2. Latin America: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.7.3. Nicotinamide Adenine Dinucleotide Market - Mexico
- 7.7.3.1. Mexico: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.7.3.2. Mexico: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.7.4. Nicotinamide Adenine Dinucleotide Market - Brazil
- 7.7.4.1. Brazil: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.7.4.2. Brazil: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
- 7.7.5. Nicotinamide Adenine Dinucleotide Market - Argentina
- 7.7.5.1. Argentina: Nicotinamide Adenine Dinucleotide Market, by Application, 2019-2032 (USD Million)
- 7.7.5.2. Argentina: Nicotinamide Adenine Dinucleotide Market, by Grade, 2019-2032 (USD Million)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Bontac Bio-engineering
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Jubilant Life Sciences
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Koninklijke DSM
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Lasons India
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Resonance Specialties
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. TCI Chemcials
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Vertellus Holdings
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Novo Nordisk
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Catalent
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Lonza Group
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Zhejiang Lanbo Biotechnology
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Otto Chemie
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Himedia Laboratories
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. NutriScience Innovations
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development